Search Count: 13
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Zika Ns5 Polymerase Domain
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2020-08-19 Classification: TRANSFERASE Ligands: ZN, G8O, FB2 |
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION
Release Date: 2020-08-19
Ligands: ZN, G8O, FB2
 |
Zika Ns5 Polymerase Domain
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2020-08-19 Classification: TRANSFERASE Ligands: ZN, G8O, G8F |
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION
Release Date: 2020-08-19
Ligands: ZN, G8O, G8F
 |
Zika Ns5 Polymerase Domain
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2020-08-19 Classification: TRANSFERASE Ligands: ZN, G8O, G8L |
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION
Release Date: 2020-08-19
Ligands: ZN, G8O, G8L
 |
Zika Ns5 Polymerase Domain
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2020-08-12 Classification: TRANSFERASE Ligands: EDO, ZN |
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION
Release Date: 2020-08-12
Ligands: EDO, ZN
 |
Zika Ns5 Polymerase Domain
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2020-08-12 Classification: TRANSFERASE Ligands: ZN, KY3 |
Organism: Zika virus (isolate zikv/human/french polynesia/10087pf/2013)
Method: X-RAY DIFFRACTION
Release Date: 2020-08-12
Ligands: ZN, KY3
 |
Crystal Structure Of The Pas-Ggdef-Eal Domain Of Pa0861 From Pseudomonas Aeruginosa
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2017-12-20 Classification: TRANSCRIPTION |
 |
Crystal Structure Of The Pas-Ggdef-Eal Domain Of Pa0861 From Pseudomonas Aeruginosa In Complex With Gtp
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2017-12-20 Classification: TRANSCRIPTION Ligands: GTP, MG |
 |
Crystal Structure Of The Pas-Ggdef-Eal Domain Of Pa0861 From Pseudomonas Aeruginosa In Complex With Cyclic Di-Gmp
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:3.31 Å Release Date: 2017-12-20 Classification: TRANSCRIPTION Ligands: C2E |